Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Arthritis Research & Therapy

Figure 3

From: Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment

Figure 3

Correlation of differences in serum levels at baseline and 1 year of (a) metalloproteinase-3 (d_MMP-3) and C-reactive protein (d_CRP), (b) vasoendothelial growth factor (d_VEGF) and d_CRP, (c) bone-specific alkaline phosphatase (d_BALP) and d_CRP, and (d) d_MMP-3 and d_BALP.

Back to article page